Efficacy of Surufatinib in Western Patients (pts) with Pancreatic Neuroendocrine Tumors (PanNETs)

被引：0
|
作者：
Dasari, A. [1 ]
Paulson, S. [2 ]
Sung, M. [3 ]
Tucci, C. [4 ]
Kauh, J. [4 ]
Kania, M. [4 ]
Li, D. [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Charles A Sammons Canc Ctr Texas Oncol, Dallas, TX USA
[3] Mt Sinai Hosp, New York, NY USA
[4] Hutchison MediPharma Int Inc, Florham Pk, NJ USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
neuroendocrine tumors; pancreatic; surufatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I02
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of surufatinib in United States (US) patients (pts) with neuroendocrine tumors (NETs).
    Dasari, Arvind
    Li, Daneng
    Sung, Max W.
    Tucci, Christopher
    Kauh, John S.
    Kania, Marek K.
    Paulson, Andrew Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Sunitinib in patients with pancreatic neuroendocrine tumors (panNETs): Exploratory pharmacogenomic analyses
    Fazio, Nicola
    Martini, Jean-Francois
    Croitoru, Adina-Emilia
    Schenker, Michael
    Li, Sherry
    Rosbrook, Brad
    Fernandez, Kathrine C.
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Kulke, Matthew H.
    Raymond, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [3] Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
    Jianwei Zhang
    Haibin Zhu
    Lin Shen
    Jie Li
    Xiaoyan Zhang
    Chunmei Bai
    Zhiwei Zhou
    Xianrui Yu
    Zhiping Li
    Enxiao Li
    Xianglin Yuan
    Wenhui Lou
    Yihebali Chi
    Nong Xu
    Yongmei Yin
    Yuxian Bai
    Tao Zhang
    Dianrong Xiu
    Jia Chen
    Shukui Qin
    Xiuwen Wang
    Yujie Yang
    Haoyun Shi
    Xian Luo
    Songhua Fan
    Weiguo Su
    Ming Lu
    Jianming Xu
    ChineseJournalofCancerResearch, 2023, 35 (05) : 526 - 541
  • [4] Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
    Zhang, Jianwei
    Zhu, Haibin
    Shen, Lin
    Li, Jie
    Zhang, Xiaoyan
    Bai, Chunmei
    Zhou, Zhiwei
    Yu, Xianrui
    Li, Zhiping
    Li, Enxiao
    Yuan, Xianglin
    Lou, Wenhui
    Chi, Yihebali
    Xu, Nong
    Yin, Yongmei
    Bai, Yuxian
    Zhang, Tao
    Xiu, Dianrong
    Chen, Jia
    Qin, Shukui
    Wang, Xiuwen
    Yang, Yujie
    Shi, Haoyun
    Luo, Xian
    Fan, Songhua
    Su, Weiguo
    Lu, Ming
    Xu, Jianming
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (05) : 526 - +
  • [5] Pancreatic neuroendocrine tumors (PanNETs) vascularization: From "micro" to "macro"
    Battistella, A.
    Andreasi, V
    Palumbo, D.
    Tacelli, M.
    de Cobelli, F.
    Arcidiacono, P. G.
    Marinoni, I
    Perren, A.
    Partelli, S.
    Falconi, M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 123 - 123
  • [6] Mechanisms of Main Pancreatic Duct Dilatation in Pancreatic Neuroendocrine Tumors (PanNETs): Radiopathologic Correlation
    Ronot, M.
    Cros, J.
    Faccinetto, A.
    de Mestier, L.
    Hentic, O.
    Sauvanet, A.
    Dokmak, S.
    Ruszniewski, P.
    Couvelard, A.
    Vullierme, M. P.
    Vilgrain, V.
    NEUROENDOCRINOLOGY, 2018, 106 : 181 - 181
  • [7] Pattern and Clinical Predictors of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors (PanNETs)
    Partelli, S.
    Cherif, R.
    Boninsegna, L.
    Gaujoux, S.
    Crippa, S.
    Couvelard, A.
    Scarpa, A.
    Ruszniewski, P.
    Sauvanet, A.
    Falconi, M.
    NEUROENDOCRINOLOGY, 2012, 96 : 53 - 53
  • [8] Surufatinib for advanced extrapancreatic neuroendocrine Tumors
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 108 - 108
  • [9] Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta-analysis
    Ali, Muhammad Ashar
    Shah, Syed S.
    Tahir, Nayha
    Rehman, Sana
    Saeed, Memoona
    Bajwa, Shammas Farooq
    Ali, Rimsha
    Aiman, Wajeeha
    Anwar, Muhammad Yasir
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (07)
  • [10] Outcomes After Cessation of Therapy With Alkylating Agents (AA) for Pancreatic Neuroendocrine Tumors (PanNETS)
    Wu, Y. Linda
    Reidy, Diane
    Bielska, Agata
    Kelly, Virginia
    Raj, Nitya
    PANCREAS, 2020, 49 (03) : 490 - 490
12345